Pam Mason

The Cleveland ClinicCleveland, Ohio - 44195 (216-445-4557) |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2009

Dose-escalation Study of the Safety Tolerability and Ability of CMX001 to Prevent or Control Cytomegalovirus (CMV) Infection in R+ Hematopoietic Stem Cell Transplant Recipients
October 2009 - October 2011
Cytomegalovirus Infections
Placebo
Cmx001



